founded in
2020
Imuno develops a structure-based discovery engine to identify cancer-specific epitopes that can be exploited by novel therapeutic strategies. Its discovery engine identifies potential cross-reactive epitopes, providing a cohesive link with conventional in-vitro safety studies. It delivers missing information and better guidance to develop safe therapies.
Something looks off?
